A mixture of 1-carvone and cis-carveol has been found to produce central nervous system (CNS) stimulatory effects when ingested. The mixture is effective at low levels and, therefore, may be incorporated into a variety of foodstuffs without imparting any undesirable off-flavors.

A method of inducing cytoprotection in mammals utilizing the prostaglandin derivative 16-methyl-1,11.alpha.,16RS-trihydroxyprost-13E-en-9-one is described.

This invention relates to an aqueous preparation comprising a compound (A) represented by the formula: ##STR1## and at least one of cyclodextrins selected from .alpha.-cyclodextrin and dimethyl-.beta.-cyclodextrin; and a method of preparation thereof. According to the aqueous preparation of this invention, coexistence with at least one medicament selected from .alpha.-cyclodextrin and dimethyl-.beta.-cyclodextrin allows to enhance the solubility to water of compound (A) essential in this inventi...

The present invention refers to new pharmaceutical compositions which contain Coenzyme Q.sub.10 in amounts from 0.0001 to 10%, dissolved or suspended in a suitable vehicle and which are useful in the pharmaceutical and cosmethological field for the topical cutaneous treatment of skin diseases and for the prophylaxis of dystrophias or dysmetabolic conditions of the cutis.

A method of killing yeast or fungi which comprises treating the yeast or fungi with a toxic amount of dihydrocarvone.

Administration of a therapeutically effective dose of 15(S)-1,11.alpha.,15.alpha.-trihydroxy-9-oxo-13-trans-prostene (1-decarboxy-1-hydroxymethyl-PGE.sub.1) produces bronchodilation in an individual in whom that therapy is indicated.

A method for preventing or treating a production disease in genetically improved livestock and poultry is provided. This method comprises orally administering to the livestock or poultry quinones such as ubiquinones. Various production diseases can be effectively prevented or treated by this method, especially production diseases caused by stress from heat or cold.

A pharmaceutical composition for treating osteoporosis which comprises as an active ingredient an effective amount of one or more compounds selected from the-group comprising humulone, cohumulone, adhumulone, isohumulone, isocohumulone and isoadhumulone in combination with a pharmaceutically acceptable carrier or excipient. Humulone, cohumulone, adhumulone are the compounds belonging to .alpha. acids which are an ingredient extracted from hops, whilst isohumulone, isocohumulone and isoadhumulone...

Topical formulations having a content of one compound or several compounds from the group consisting of ubiquinones and derivatives thereof in combination with a content of one compound or several compounds from the group consisting of plastoquinones and derivatives thereof or formulations having a content of one compound or several compounds from the group consisting of plastoquinones and derivatives thereof.

The present invention provides pharmaceutical compositions comprising an amount of hydrogenated lupulones or derivatives or analogs thereof, effective to inhibit cancer cell growth, and methods of use thereof.